efavirenz has been researched along with Cognitive Decline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Hu, K; Li, W; Qian, F; Qiao, J; Sun, B; Zhang, R | 1 |
| Bisaso, KR; Bisaso, KS; Ette, EI; Mukonzo, JK | 1 |
| Alagaratnam, J; Boffito, M; Bozzali, M; Cercignani, M; Mora-Peris, B; Nelson, M; Toniolo, S; Underwood, J; Vera, JH; Winston, A | 1 |
| Arends, JE; Hakkers, CS; Hermans, AM; Hoepelman, AIM; Teunissen, CE; van Maarseveen, EM; Verberk, IMW | 1 |
| Bonora, S; Calcagno, A; De Benedetto, I; Guastamacchia, G; Trunfio, M | 1 |
| Aklillu, E; Gustafsson, LL; Luzze, H; Mukonzo, JK; Nakasujja, N; Ogwal-Okeng, J; Okwera, A; Sebuwufu, D; Waako, P | 1 |
| Clifford, DB; Collier, AC; Croteau, D; Gelman, BB; Grant, I; Heaton, RK; Kao, YT; Letendre, SL; Ma, Q; Marra, CM; McArthur, JC; Morgello, S; Sanders, CA; Simpson, DM; Vaida, F; Wong, J | 1 |
1 review(s) available for efavirenz and Cognitive Decline
| Article | Year |
|---|---|
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Astrocytes; Atazanavir Sulfate; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Cyclopropanes; Dideoxynucleosides; Endothelial Cells; HIV Infections; Humans; Neurons; Nevirapine; Nitriles; Oligodendroglia; Pyrimidines | 2020 |
1 trial(s) available for efavirenz and Cognitive Decline
| Article | Year |
|---|---|
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Asymptomatic Diseases; Attention; Benzoxazines; Biomarkers; Cognitive Dysfunction; Cyclopropanes; Executive Function; Female; HIV Infections; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Neurofilament Proteins; Rilpivirine; Speech | 2020 |
5 other study(ies) available for efavirenz and Cognitive Decline
| Article | Year |
|---|---|
Long-term efavirenz exposure induced neuroinflammation and cognitive deficits in C57BL/6 mice.
Topics: Alkynes; Animals; Benzoxazines; Cognition; Cognitive Dysfunction; Cyclopropanes; Hippocampus; Humans; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Neuroinflammatory Diseases; Reverse Transcriptase Inhibitors; Spatial Learning; Synapsins; Synaptophysin; Synaptotagmin I; Time Factors | 2021 |
Maximizing Knowledge Extraction From Patient-Reported Outcome Data Using Exposure-Outcome Item Response Modeling Approach: Understanding Efavirenz-Induced Central Nervous System Toxicity.
Topics: Alkynes; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Computer Simulation; Cyclopropanes; Disease Progression; Drug Administration Schedule; Hallucinations; HIV Infections; Humans; Models, Psychological; Patient Reported Outcome Measures; Patient-Specific Modeling; Reverse Transcriptase Inhibitors; Severity of Illness Index; Sleep Wake Disorders; Symptom Assessment; Time Factors | 2020 |
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asymptomatic Diseases; Benzoxazines; Cognitive Dysfunction; Connectome; Cyclopropanes; Drug Substitution; Emtricitabine; Executive Function; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxazines; Piperazines; Prospective Studies; Pyridones; Raltegravir Potassium; Rilpivirine; Tenofovir | 2020 |
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.
Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cognitive Dysfunction; Constitutive Androstane Receptor; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Gene Frequency; Hallucinations; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Memory Disorders; Mental Disorders; Prospective Studies; Rifampin; Sleep Arousal Disorders; Tuberculosis; Uganda | 2013 |
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cognitive Dysfunction; Coinfection; Cyclopropanes; Drug Therapy, Combination; Executive Function; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Lopinavir; Male; Memory; Middle Aged; Neuropsychological Tests; Ritonavir; Verbal Learning | 2016 |